By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than 8 million deaths around the world every year.

PTC Inc. stock is a Buy as Creo & Windchill drive R&D lock-in, 27% RPO growth, and 95% recurring revenue, plus $365M buybacks. Click here to read more on PTC.

This is what the software-defined vehicle looks like in practice. Fewer chips, more consolidation, and far more dependence on ...

The new technology, Ström-Awn said, “defaults to the same aesthetic for every single person that’s using it.” As Claude ...

The path from block-based programming to vibe coding represents a shift from mastering the mechanics of implementation to ...